nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—Small Ligand GPCRs—CNR2—osteoporosis	0.0198	0.0616	CbGpPWpGaD
Misoprostol—PTGER4—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.0195	0.0606	CbGpPWpGaD
Misoprostol—PTGER2—Small Ligand GPCRs—CNR2—osteoporosis	0.0163	0.0505	CbGpPWpGaD
Misoprostol—PTGER2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.016	0.0498	CbGpPWpGaD
Misoprostol—PTGER3—Small Ligand GPCRs—CNR2—osteoporosis	0.015	0.0466	CbGpPWpGaD
Misoprostol—PTGER3—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.0148	0.0459	CbGpPWpGaD
Misoprostol—Dinoprostone—SLC51A—osteoporosis	0.0125	0.842	CrCbGaD
Misoprostol—PTGER4—G alpha (s) signalling events—CALCR—osteoporosis	0.00864	0.0268	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—PTH1R—osteoporosis	0.00864	0.0268	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—ESR2—osteoporosis	0.0077	0.0239	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—CALCR—osteoporosis	0.00709	0.022	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—PTH1R—osteoporosis	0.00709	0.022	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—CYP19A1—osteoporosis	0.00699	0.0217	CbGpPWpGaD
Misoprostol—PTGER2—Ovarian Infertility Genes—VDR—osteoporosis	0.00611	0.019	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—PTH—osteoporosis	0.00454	0.0141	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—PTHLH—osteoporosis	0.00376	0.0117	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—PTH—osteoporosis	0.00373	0.0116	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—CALCA—osteoporosis	0.00331	0.0103	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CALCR—osteoporosis	0.00314	0.00973	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—PTH1R—osteoporosis	0.00314	0.00973	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—PTHLH—osteoporosis	0.00309	0.00958	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—CALCA—osteoporosis	0.00272	0.00844	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—PTH1R—osteoporosis	0.00257	0.00799	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CALCR—osteoporosis	0.00257	0.00799	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00246	0.00764	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CALCR—osteoporosis	0.00238	0.00738	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—PTH1R—osteoporosis	0.00238	0.00738	CbGpPWpGaD
Misoprostol—Dinoprostone—CYP19A1—osteoporosis	0.00236	0.158	CrCbGaD
Misoprostol—PTGER4—G alpha (s) signalling events—ADCY5—osteoporosis	0.00235	0.00731	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00211	0.00654	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00202	0.00627	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CNR2—osteoporosis	0.00201	0.00624	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—ADCY5—osteoporosis	0.00193	0.006	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00186	0.00579	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CALCR—osteoporosis	0.00177	0.0055	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PTH1R—osteoporosis	0.00177	0.0055	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—POMC—osteoporosis	0.00173	0.00538	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00173	0.00537	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—PTH—osteoporosis	0.00165	0.00511	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PTH1R—osteoporosis	0.00161	0.005	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CALCR—osteoporosis	0.00161	0.005	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CNR2—osteoporosis	0.00161	0.00498	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.0016	0.00496	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—WNT1—osteoporosis	0.00151	0.00468	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CALCR—osteoporosis	0.00146	0.00452	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PTH1R—osteoporosis	0.00146	0.00452	CbGpPWpGaD
Misoprostol—PTGER2—G alpha (s) signalling events—POMC—osteoporosis	0.00142	0.00441	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—MGLL—osteoporosis	0.00141	0.00437	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—PTHLH—osteoporosis	0.00136	0.00424	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—PTH—osteoporosis	0.00135	0.0042	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CALCR—osteoporosis	0.00134	0.00417	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—PTH1R—osteoporosis	0.00134	0.00417	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—PTH1R—osteoporosis	0.00132	0.0041	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CALCR—osteoporosis	0.00132	0.0041	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CNR2—osteoporosis	0.00132	0.00409	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—MGLL—osteoporosis	0.00128	0.00397	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—PTH—osteoporosis	0.00125	0.00388	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—WNT1—osteoporosis	0.00124	0.00385	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CALCR—osteoporosis	0.00122	0.00379	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—PTH1R—osteoporosis	0.00122	0.00379	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CNR2—osteoporosis	0.00122	0.00378	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CALCA—osteoporosis	0.0012	0.00373	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—MGLL—osteoporosis	0.00116	0.00359	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—WNT1—osteoporosis	0.00114	0.00355	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—PTHLH—osteoporosis	0.00112	0.00348	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—ADCY5—osteoporosis	0.00107	0.00332	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—MGLL—osteoporosis	0.00107	0.00331	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SOST—osteoporosis	0.00105	0.00326	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—MGLL—osteoporosis	0.00105	0.00326	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—PTHLH—osteoporosis	0.00103	0.00321	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CALCA—osteoporosis	0.000987	0.00306	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—MGLL—osteoporosis	0.000969	0.00301	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CALCR—osteoporosis	0.000951	0.00295	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PTH1R—osteoporosis	0.000951	0.00295	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PTH—osteoporosis	0.000931	0.00289	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CALCA—osteoporosis	0.000911	0.00283	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CNR2—osteoporosis	0.000907	0.00282	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SOST—osteoporosis	0.000863	0.00268	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—PTH—osteoporosis	0.000845	0.00262	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000826	0.00256	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CNR2—osteoporosis	0.000824	0.00256	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SOST—osteoporosis	0.000797	0.00247	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—POMC—osteoporosis	0.000787	0.00244	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTH1R—osteoporosis	0.000781	0.00242	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CALCR—osteoporosis	0.000781	0.00242	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—WNT1—osteoporosis	0.000774	0.0024	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—PTHLH—osteoporosis	0.000771	0.00239	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—PTH—osteoporosis	0.000764	0.00237	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MGLL—osteoporosis	0.000755	0.00234	CbGpPWpGaD
Misoprostol—Loss of consciousness—Pamidronate—osteoporosis	0.000748	0.00113	CcSEcCtD
Misoprostol—Muscle spasms—Zoledronate—osteoporosis	0.000748	0.00113	CcSEcCtD
Misoprostol—Conjunctivitis—Estradiol—osteoporosis	0.000745	0.00112	CcSEcCtD
Misoprostol—Urinary tract infection—Estradiol—osteoporosis	0.000745	0.00112	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CNR2—osteoporosis	0.000745	0.00231	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Alendronate—osteoporosis	0.000745	0.00112	CcSEcCtD
Misoprostol—Infection—Ethinyl Estradiol—osteoporosis	0.000745	0.00112	CcSEcCtD
Misoprostol—Pain—Calcitriol—osteoporosis	0.000742	0.00112	CcSEcCtD
Misoprostol—Constipation—Calcitriol—osteoporosis	0.000742	0.00112	CcSEcCtD
Misoprostol—Flatulence—Conjugated Estrogens—osteoporosis	0.000738	0.00111	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—LRP5—osteoporosis	0.000737	0.00229	CbGpPWpGaD
Misoprostol—Hypertension—Pamidronate—osteoporosis	0.000735	0.00111	CcSEcCtD
Misoprostol—Gastrointestinal pain—Raloxifene—osteoporosis	0.000732	0.0011	CcSEcCtD
Misoprostol—Diarrhoea—Etidronic acid—osteoporosis	0.000731	0.0011	CcSEcCtD
Misoprostol—Haematuria—Estradiol—osteoporosis	0.000731	0.0011	CcSEcCtD
Misoprostol—Body temperature increased—Estropipate—osteoporosis	0.000731	0.0011	CcSEcCtD
Misoprostol—Abdominal pain—Estropipate—osteoporosis	0.000731	0.0011	CcSEcCtD
Misoprostol—Feeling abnormal—Ibandronate—osteoporosis	0.000731	0.0011	CcSEcCtD
Misoprostol—Infection—Risedronate—osteoporosis	0.000726	0.0011	CcSEcCtD
Misoprostol—Gastrointestinal pain—Ibandronate—osteoporosis	0.000725	0.00109	CcSEcCtD
Misoprostol—Arthralgia—Pamidronate—osteoporosis	0.000725	0.00109	CcSEcCtD
Misoprostol—Myalgia—Pamidronate—osteoporosis	0.000725	0.00109	CcSEcCtD
Misoprostol—Back pain—Conjugated Estrogens—osteoporosis	0.000724	0.00109	CcSEcCtD
Misoprostol—Epistaxis—Estradiol—osteoporosis	0.000723	0.00109	CcSEcCtD
Misoprostol—Anxiety—Pamidronate—osteoporosis	0.000722	0.00109	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CALCR—osteoporosis	0.00072	0.00224	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTH1R—osteoporosis	0.00072	0.00224	CbGpPWpGaD
Misoprostol—Body temperature increased—Alendronate—osteoporosis	0.00072	0.00109	CcSEcCtD
Misoprostol—Abdominal pain—Alendronate—osteoporosis	0.00072	0.00109	CcSEcCtD
Misoprostol—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00072	0.00109	CcSEcCtD
Misoprostol—Shock—Risedronate—osteoporosis	0.000719	0.00108	CcSEcCtD
Misoprostol—Anaemia—Zoledronate—osteoporosis	0.000719	0.00108	CcSEcCtD
Misoprostol—Gastrointestinal pain—Calcitriol—osteoporosis	0.00071	0.00107	CcSEcCtD
Misoprostol—Abdominal pain—Raloxifene—osteoporosis	0.000708	0.00107	CcSEcCtD
Misoprostol—Body temperature increased—Raloxifene—osteoporosis	0.000708	0.00107	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PTH—osteoporosis	0.000705	0.00219	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LRP6—osteoporosis	0.000705	0.00219	CbGpPWpGaD
Misoprostol—Body temperature increased—Ibandronate—osteoporosis	0.000701	0.00106	CcSEcCtD
Misoprostol—Abdominal pain—Ibandronate—osteoporosis	0.000701	0.00106	CcSEcCtD
Misoprostol—Confusional state—Pamidronate—osteoporosis	0.0007	0.00106	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—PTHLH—osteoporosis	0.0007	0.00217	CbGpPWpGaD
Misoprostol—Syncope—Zoledronate—osteoporosis	0.000697	0.00105	CcSEcCtD
Misoprostol—Anaphylactic shock—Pamidronate—osteoporosis	0.000695	0.00105	CcSEcCtD
Misoprostol—Oedema—Pamidronate—osteoporosis	0.000695	0.00105	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PTH—osteoporosis	0.000694	0.00215	CbGpPWpGaD
Misoprostol—Infection—Pamidronate—osteoporosis	0.00069	0.00104	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CNR2—osteoporosis	0.000687	0.00213	CbGpPWpGaD
Misoprostol—Body temperature increased—Calcitriol—osteoporosis	0.000686	0.00104	CcSEcCtD
Misoprostol—Abdominal pain—Calcitriol—osteoporosis	0.000686	0.00104	CcSEcCtD
Misoprostol—Shock—Pamidronate—osteoporosis	0.000683	0.00103	CcSEcCtD
Misoprostol—Loss of consciousness—Zoledronate—osteoporosis	0.000683	0.00103	CcSEcCtD
Misoprostol—Hypersensitivity—Estropipate—osteoporosis	0.000681	0.00103	CcSEcCtD
Misoprostol—Thrombocytopenia—Pamidronate—osteoporosis	0.00068	0.00103	CcSEcCtD
Misoprostol—Vomiting—Etidronic acid—osteoporosis	0.00068	0.00103	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CALCA—osteoporosis	0.000679	0.00211	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000678	0.0021	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CNR2—osteoporosis	0.000676	0.0021	CbGpPWpGaD
Misoprostol—Rash—Etidronic acid—osteoporosis	0.000674	0.00102	CcSEcCtD
Misoprostol—Dermatitis—Etidronic acid—osteoporosis	0.000673	0.00102	CcSEcCtD
Misoprostol—Hyperhidrosis—Pamidronate—osteoporosis	0.000672	0.00101	CcSEcCtD
Misoprostol—Syncope—Conjugated Estrogens—osteoporosis	0.000671	0.00101	CcSEcCtD
Misoprostol—Hypertension—Zoledronate—osteoporosis	0.000671	0.00101	CcSEcCtD
Misoprostol—Hypersensitivity—Alendronate—osteoporosis	0.000671	0.00101	CcSEcCtD
Misoprostol—Headache—Etidronic acid—osteoporosis	0.00067	0.00101	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000666	0.001	CcSEcCtD
Misoprostol—Asthenia—Estropipate—osteoporosis	0.000663	0.001	CcSEcCtD
Misoprostol—Visual impairment—Estradiol—osteoporosis	0.000663	0.001	CcSEcCtD
Misoprostol—Myalgia—Zoledronate—osteoporosis	0.000662	0.000998	CcSEcCtD
Misoprostol—Chest pain—Zoledronate—osteoporosis	0.000662	0.000998	CcSEcCtD
Misoprostol—Arthralgia—Zoledronate—osteoporosis	0.000662	0.000998	CcSEcCtD
Misoprostol—Anxiety—Zoledronate—osteoporosis	0.00066	0.000995	CcSEcCtD
Misoprostol—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000658	0.000993	CcSEcCtD
Misoprostol—Asthenia—Alendronate—osteoporosis	0.000653	0.000986	CcSEcCtD
Misoprostol—Hypersensitivity—Ibandronate—osteoporosis	0.000653	0.000985	CcSEcCtD
Misoprostol—Dyspnoea—Risedronate—osteoporosis	0.000652	0.000983	CcSEcCtD
Misoprostol—Hypotension—Pamidronate—osteoporosis	0.000649	0.000979	CcSEcCtD
Misoprostol—Fatigue—Ethinyl Estradiol—osteoporosis	0.000646	0.000975	CcSEcCtD
Misoprostol—Dyspepsia—Risedronate—osteoporosis	0.000643	0.00097	CcSEcCtD
Misoprostol—Tinnitus—Estradiol—osteoporosis	0.000642	0.000968	CcSEcCtD
Misoprostol—Constipation—Ethinyl Estradiol—osteoporosis	0.000641	0.000967	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PTH—osteoporosis	0.000641	0.00199	CbGpPWpGaD
Misoprostol—Confusional state—Zoledronate—osteoporosis	0.00064	0.000965	CcSEcCtD
Misoprostol—Hypersensitivity—Calcitriol—osteoporosis	0.00064	0.000965	CcSEcCtD
Misoprostol—Arthralgia—Conjugated Estrogens—osteoporosis	0.000637	0.000961	CcSEcCtD
Misoprostol—Myalgia—Conjugated Estrogens—osteoporosis	0.000637	0.000961	CcSEcCtD
Misoprostol—Chest pain—Conjugated Estrogens—osteoporosis	0.000637	0.000961	CcSEcCtD
Misoprostol—Asthenia—Ibandronate—osteoporosis	0.000636	0.00096	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—WNT1—osteoporosis	0.000636	0.00197	CbGpPWpGaD
Misoprostol—Anxiety—Conjugated Estrogens—osteoporosis	0.000635	0.000958	CcSEcCtD
Misoprostol—Nausea—Etidronic acid—osteoporosis	0.000635	0.000958	CcSEcCtD
Misoprostol—Anaphylactic shock—Zoledronate—osteoporosis	0.000635	0.000957	CcSEcCtD
Misoprostol—Oedema—Zoledronate—osteoporosis	0.000635	0.000957	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—PTHLH—osteoporosis	0.000633	0.00197	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000633	0.000955	CcSEcCtD
Misoprostol—Diarrhoea—Estropipate—osteoporosis	0.000633	0.000954	CcSEcCtD
Misoprostol—Infection—Zoledronate—osteoporosis	0.00063	0.000951	CcSEcCtD
Misoprostol—Fatigue—Risedronate—osteoporosis	0.00063	0.00095	CcSEcCtD
Misoprostol—PTGER4—GPCR ligand binding—POMC—osteoporosis	0.000629	0.00195	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000626	0.00194	CbGpPWpGaD
Misoprostol—Pain—Risedronate—osteoporosis	0.000625	0.000943	CcSEcCtD
Misoprostol—Constipation—Risedronate—osteoporosis	0.000625	0.000943	CcSEcCtD
Misoprostol—Shock—Zoledronate—osteoporosis	0.000624	0.000942	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CNR2—osteoporosis	0.000624	0.00194	CbGpPWpGaD
Misoprostol—Diarrhoea—Alendronate—osteoporosis	0.000623	0.00094	CcSEcCtD
Misoprostol—Asthenia—Calcitriol—osteoporosis	0.000623	0.000939	CcSEcCtD
Misoprostol—Immune system disorder—Estradiol—osteoporosis	0.000622	0.000938	CcSEcCtD
Misoprostol—Thrombocytopenia—Zoledronate—osteoporosis	0.000621	0.000937	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—MGLL—osteoporosis	0.00062	0.00193	CbGpPWpGaD
Misoprostol—Dyspnoea—Pamidronate—osteoporosis	0.000619	0.000934	CcSEcCtD
Misoprostol—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000618	0.000932	CcSEcCtD
Misoprostol—Chills—Estradiol—osteoporosis	0.000618	0.000932	CcSEcCtD
Misoprostol—Somnolence—Pamidronate—osteoporosis	0.000618	0.000932	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CALCA—osteoporosis	0.000617	0.00191	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Zoledronate—osteoporosis	0.000613	0.000925	CcSEcCtD
Misoprostol—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000613	0.000925	CcSEcCtD
Misoprostol—Diarrhoea—Raloxifene—osteoporosis	0.000613	0.000924	CcSEcCtD
Misoprostol—Dyspepsia—Pamidronate—osteoporosis	0.000612	0.000922	CcSEcCtD
Misoprostol—Dizziness—Estropipate—osteoporosis	0.000611	0.000922	CcSEcCtD
Misoprostol—Oedema—Conjugated Estrogens—osteoporosis	0.000611	0.000922	CcSEcCtD
Misoprostol—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000611	0.000922	CcSEcCtD
Misoprostol—Alopecia—Estradiol—osteoporosis	0.000608	0.000917	CcSEcCtD
Misoprostol—Infection—Conjugated Estrogens—osteoporosis	0.000607	0.000916	CcSEcCtD
Misoprostol—Diarrhoea—Ibandronate—osteoporosis	0.000607	0.000915	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—LRP5—osteoporosis	0.000605	0.00188	CbGpPWpGaD
Misoprostol—Dizziness—Alendronate—osteoporosis	0.000602	0.000908	CcSEcCtD
Misoprostol—Shock—Conjugated Estrogens—osteoporosis	0.000601	0.000907	CcSEcCtD
Misoprostol—Fatigue—Pamidronate—osteoporosis	0.000599	0.000903	CcSEcCtD
Misoprostol—Gastrointestinal pain—Risedronate—osteoporosis	0.000598	0.000901	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—TLN1—osteoporosis	0.000595	0.00185	CbGpPWpGaD
Misoprostol—Constipation—Pamidronate—osteoporosis	0.000594	0.000896	CcSEcCtD
Misoprostol—Pain—Pamidronate—osteoporosis	0.000594	0.000896	CcSEcCtD
Misoprostol—Diarrhoea—Calcitriol—osteoporosis	0.000594	0.000896	CcSEcCtD
Misoprostol—Hypotension—Zoledronate—osteoporosis	0.000593	0.000894	CcSEcCtD
Misoprostol—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000593	0.000894	CcSEcCtD
Misoprostol—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000593	0.000894	CcSEcCtD
Misoprostol—Dizziness—Raloxifene—osteoporosis	0.000592	0.000893	CcSEcCtD
Misoprostol—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000591	0.000891	CcSEcCtD
Misoprostol—Flatulence—Estradiol—osteoporosis	0.00059	0.000891	CcSEcCtD
Misoprostol—Vomiting—Estropipate—osteoporosis	0.000588	0.000887	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—WNT1—osteoporosis	0.000587	0.00182	CbGpPWpGaD
Misoprostol—Dizziness—Ibandronate—osteoporosis	0.000586	0.000884	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—PTHLH—osteoporosis	0.000585	0.00181	CbGpPWpGaD
Misoprostol—Rash—Estropipate—osteoporosis	0.000583	0.000879	CcSEcCtD
Misoprostol—Dermatitis—Estropipate—osteoporosis	0.000583	0.000879	CcSEcCtD
Misoprostol—Back pain—Estradiol—osteoporosis	0.00058	0.000874	CcSEcCtD
Misoprostol—Headache—Estropipate—osteoporosis	0.000579	0.000874	CcSEcCtD
Misoprostol—Vomiting—Alendronate—osteoporosis	0.000579	0.000873	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—LRP6—osteoporosis	0.000579	0.0018	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000578	0.000872	CcSEcCtD
Misoprostol—Abdominal pain—Risedronate—osteoporosis	0.000578	0.000871	CcSEcCtD
Misoprostol—Body temperature increased—Risedronate—osteoporosis	0.000578	0.000871	CcSEcCtD
Misoprostol—Muscle spasms—Estradiol—osteoporosis	0.000576	0.000869	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—PTHLH—osteoporosis	0.000575	0.00179	CbGpPWpGaD
Misoprostol—Rash—Alendronate—osteoporosis	0.000574	0.000866	CcSEcCtD
Misoprostol—Dermatitis—Alendronate—osteoporosis	0.000574	0.000865	CcSEcCtD
Misoprostol—Feeling abnormal—Pamidronate—osteoporosis	0.000572	0.000864	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—MGLL—osteoporosis	0.000572	0.00178	CbGpPWpGaD
Misoprostol—Hypotension—Conjugated Estrogens—osteoporosis	0.000571	0.000861	CcSEcCtD
Misoprostol—Headache—Alendronate—osteoporosis	0.000571	0.000861	CcSEcCtD
Misoprostol—Vomiting—Raloxifene—osteoporosis	0.00057	0.000859	CcSEcCtD
Misoprostol—Gastrointestinal pain—Pamidronate—osteoporosis	0.000568	0.000857	CcSEcCtD
Misoprostol—Dyspnoea—Zoledronate—osteoporosis	0.000566	0.000853	CcSEcCtD
Misoprostol—Rash—Raloxifene—osteoporosis	0.000565	0.000852	CcSEcCtD
Misoprostol—Dermatitis—Raloxifene—osteoporosis	0.000564	0.000851	CcSEcCtD
Misoprostol—Somnolence—Zoledronate—osteoporosis	0.000564	0.000851	CcSEcCtD
Misoprostol—Vomiting—Ibandronate—osteoporosis	0.000564	0.00085	CcSEcCtD
Misoprostol—Headache—Raloxifene—osteoporosis	0.000561	0.000846	CcSEcCtD
Misoprostol—Rash—Ibandronate—osteoporosis	0.000559	0.000843	CcSEcCtD
Misoprostol—Dermatitis—Ibandronate—osteoporosis	0.000559	0.000843	CcSEcCtD
Misoprostol—Dyspepsia—Zoledronate—osteoporosis	0.000559	0.000843	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—LRP5—osteoporosis	0.000559	0.00173	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CALCA—osteoporosis	0.000558	0.00173	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000557	0.00084	CcSEcCtD
Misoprostol—Headache—Ibandronate—osteoporosis	0.000556	0.000838	CcSEcCtD
Misoprostol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000552	0.000833	CcSEcCtD
Misoprostol—Vomiting—Calcitriol—osteoporosis	0.000552	0.000833	CcSEcCtD
Misoprostol—Nausea—Estropipate—osteoporosis	0.000549	0.000829	CcSEcCtD
Misoprostol—Body temperature increased—Pamidronate—osteoporosis	0.000549	0.000828	CcSEcCtD
Misoprostol—Abdominal pain—Pamidronate—osteoporosis	0.000549	0.000828	CcSEcCtD
Misoprostol—Rash—Calcitriol—osteoporosis	0.000547	0.000826	CcSEcCtD
Misoprostol—Fatigue—Zoledronate—osteoporosis	0.000547	0.000825	CcSEcCtD
Misoprostol—Dermatitis—Calcitriol—osteoporosis	0.000547	0.000825	CcSEcCtD
Misoprostol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000545	0.000822	CcSEcCtD
Misoprostol—Headache—Calcitriol—osteoporosis	0.000544	0.00082	CcSEcCtD
Misoprostol—Somnolence—Conjugated Estrogens—osteoporosis	0.000543	0.000819	CcSEcCtD
Misoprostol—Constipation—Zoledronate—osteoporosis	0.000543	0.000819	CcSEcCtD
Misoprostol—Pain—Zoledronate—osteoporosis	0.000543	0.000819	CcSEcCtD
Misoprostol—Nausea—Alendronate—osteoporosis	0.000541	0.000816	CcSEcCtD
Misoprostol—Hypersensitivity—Risedronate—osteoporosis	0.000538	0.000812	CcSEcCtD
Misoprostol—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000538	0.000811	CcSEcCtD
Misoprostol—Asthenia—Ethinyl Estradiol—osteoporosis	0.000538	0.000811	CcSEcCtD
Misoprostol—Syncope—Estradiol—osteoporosis	0.000537	0.000811	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—LRP6—osteoporosis	0.000534	0.00166	CbGpPWpGaD
Misoprostol—Nausea—Raloxifene—osteoporosis	0.000532	0.000803	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—PTHLH—osteoporosis	0.000531	0.00165	CbGpPWpGaD
Misoprostol—Fatigue—Conjugated Estrogens—osteoporosis	0.000527	0.000795	CcSEcCtD
Misoprostol—Nausea—Ibandronate—osteoporosis	0.000527	0.000794	CcSEcCtD
Misoprostol—Loss of consciousness—Estradiol—osteoporosis	0.000527	0.000794	CcSEcCtD
Misoprostol—Asthenia—Risedronate—osteoporosis	0.000524	0.000791	CcSEcCtD
Misoprostol—Feeling abnormal—Zoledronate—osteoporosis	0.000523	0.000789	CcSEcCtD
Misoprostol—Pain—Conjugated Estrogens—osteoporosis	0.000523	0.000788	CcSEcCtD
Misoprostol—Constipation—Conjugated Estrogens—osteoporosis	0.000523	0.000788	CcSEcCtD
Misoprostol—Gastrointestinal pain—Zoledronate—osteoporosis	0.000519	0.000783	CcSEcCtD
Misoprostol—Hypertension—Estradiol—osteoporosis	0.000517	0.00078	CcSEcCtD
Misoprostol—PTGER2—GPCR ligand binding—POMC—osteoporosis	0.000516	0.0016	CbGpPWpGaD
Misoprostol—Nausea—Calcitriol—osteoporosis	0.000516	0.000778	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CALCA—osteoporosis	0.000515	0.0016	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—P4HB—osteoporosis	0.000513	0.00159	CbGpPWpGaD
Misoprostol—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000513	0.000774	CcSEcCtD
Misoprostol—Hypersensitivity—Pamidronate—osteoporosis	0.000512	0.000772	CcSEcCtD
Misoprostol—Myalgia—Estradiol—osteoporosis	0.00051	0.000769	CcSEcCtD
Misoprostol—Chest pain—Estradiol—osteoporosis	0.00051	0.000769	CcSEcCtD
Misoprostol—Arthralgia—Estradiol—osteoporosis	0.00051	0.000769	CcSEcCtD
Misoprostol—Anxiety—Estradiol—osteoporosis	0.000508	0.000767	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CALCA—osteoporosis	0.000506	0.00157	CbGpPWpGaD
Misoprostol—Body temperature increased—Zoledronate—osteoporosis	0.000502	0.000757	CcSEcCtD
Misoprostol—Abdominal pain—Zoledronate—osteoporosis	0.000502	0.000757	CcSEcCtD
Misoprostol—Diarrhoea—Risedronate—osteoporosis	0.0005	0.000754	CcSEcCtD
Misoprostol—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.0005	0.000754	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PTH—osteoporosis	0.000499	0.00155	CbGpPWpGaD
Misoprostol—Asthenia—Pamidronate—osteoporosis	0.000498	0.000752	CcSEcCtD
Misoprostol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000496	0.000748	CcSEcCtD
Misoprostol—Confusional state—Estradiol—osteoporosis	0.000493	0.000744	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—RAP1A—osteoporosis	0.000491	0.00152	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Estradiol—osteoporosis	0.000489	0.000738	CcSEcCtD
Misoprostol—Oedema—Estradiol—osteoporosis	0.000489	0.000738	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—TLN1—osteoporosis	0.000489	0.00152	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CNR2—osteoporosis	0.000487	0.00151	CbGpPWpGaD
Misoprostol—Infection—Estradiol—osteoporosis	0.000486	0.000733	CcSEcCtD
Misoprostol—Dizziness—Risedronate—osteoporosis	0.000483	0.000729	CcSEcCtD
Misoprostol—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000483	0.000729	CcSEcCtD
Misoprostol—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000483	0.000729	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—ADCY5—osteoporosis	0.000483	0.0015	CbGpPWpGaD
Misoprostol—Shock—Estradiol—osteoporosis	0.000481	0.000726	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—NFATC1—osteoporosis	0.000479	0.00149	CbGpPWpGaD
Misoprostol—Vomiting—Ethinyl Estradiol—osteoporosis	0.000477	0.000719	CcSEcCtD
Misoprostol—PTGER3—GPCR ligand binding—POMC—osteoporosis	0.000476	0.00148	CbGpPWpGaD
Misoprostol—Diarrhoea—Pamidronate—osteoporosis	0.000475	0.000717	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—DKK1—osteoporosis	0.000475	0.00147	CbGpPWpGaD
Misoprostol—Hyperhidrosis—Estradiol—osteoporosis	0.000473	0.000713	CcSEcCtD
Misoprostol—Rash—Ethinyl Estradiol—osteoporosis	0.000473	0.000713	CcSEcCtD
Misoprostol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000472	0.000712	CcSEcCtD
Misoprostol—Headache—Ethinyl Estradiol—osteoporosis	0.00047	0.000708	CcSEcCtD
Misoprostol—Hypersensitivity—Zoledronate—osteoporosis	0.000468	0.000705	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CALCA—osteoporosis	0.000467	0.00145	CbGpPWpGaD
Misoprostol—Vomiting—Risedronate—osteoporosis	0.000465	0.000701	CcSEcCtD
Misoprostol—Rash—Risedronate—osteoporosis	0.000461	0.000695	CcSEcCtD
Misoprostol—Dermatitis—Risedronate—osteoporosis	0.00046	0.000694	CcSEcCtD
Misoprostol—Dizziness—Pamidronate—osteoporosis	0.000459	0.000693	CcSEcCtD
Misoprostol—Headache—Risedronate—osteoporosis	0.000458	0.000691	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—WNT1—osteoporosis	0.000457	0.00142	CbGpPWpGaD
Misoprostol—Asthenia—Zoledronate—osteoporosis	0.000455	0.000687	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—TLN1—osteoporosis	0.000451	0.0014	CbGpPWpGaD
Misoprostol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00045	0.000679	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000446	0.000672	CcSEcCtD
Misoprostol—Nausea—Ethinyl Estradiol—osteoporosis	0.000445	0.000672	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FGA—osteoporosis	0.000445	0.00138	CbGpPWpGaD
Misoprostol—Vomiting—Pamidronate—osteoporosis	0.000442	0.000666	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—ADCY5—osteoporosis	0.000439	0.00136	CbGpPWpGaD
Misoprostol—Asthenia—Conjugated Estrogens—osteoporosis	0.000438	0.000661	CcSEcCtD
Misoprostol—Rash—Pamidronate—osteoporosis	0.000438	0.000661	CcSEcCtD
Misoprostol—Dermatitis—Pamidronate—osteoporosis	0.000438	0.00066	CcSEcCtD
Misoprostol—Dyspnoea—Estradiol—osteoporosis	0.000436	0.000658	CcSEcCtD
Misoprostol—Headache—Pamidronate—osteoporosis	0.000435	0.000656	CcSEcCtD
Misoprostol—Somnolence—Estradiol—osteoporosis	0.000435	0.000656	CcSEcCtD
Misoprostol—Diarrhoea—Zoledronate—osteoporosis	0.000434	0.000655	CcSEcCtD
Misoprostol—Nausea—Risedronate—osteoporosis	0.000434	0.000655	CcSEcCtD
Misoprostol—Dyspepsia—Estradiol—osteoporosis	0.00043	0.000649	CcSEcCtD
Misoprostol—Fatigue—Estradiol—osteoporosis	0.000422	0.000636	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—P4HB—osteoporosis	0.000422	0.00131	CbGpPWpGaD
Misoprostol—Dizziness—Zoledronate—osteoporosis	0.00042	0.000633	CcSEcCtD
Misoprostol—Pain—Estradiol—osteoporosis	0.000418	0.000631	CcSEcCtD
Misoprostol—Constipation—Estradiol—osteoporosis	0.000418	0.000631	CcSEcCtD
Misoprostol—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000418	0.000631	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—PTHLH—osteoporosis	0.000414	0.00128	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—BMP2—osteoporosis	0.000414	0.00128	CbGpPWpGaD
Misoprostol—Nausea—Pamidronate—osteoporosis	0.000413	0.000622	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—PTH—osteoporosis	0.00041	0.00127	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—FGB—osteoporosis	0.000405	0.00126	CbGpPWpGaD
Misoprostol—Dizziness—Conjugated Estrogens—osteoporosis	0.000404	0.000609	CcSEcCtD
Misoprostol—Vomiting—Zoledronate—osteoporosis	0.000403	0.000609	CcSEcCtD
Misoprostol—Feeling abnormal—Estradiol—osteoporosis	0.000403	0.000608	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—RAP1A—osteoporosis	0.000403	0.00125	CbGpPWpGaD
Misoprostol—Rash—Zoledronate—osteoporosis	0.0004	0.000604	CcSEcCtD
Misoprostol—Gastrointestinal pain—Estradiol—osteoporosis	0.0004	0.000603	CcSEcCtD
Misoprostol—Dermatitis—Zoledronate—osteoporosis	0.0004	0.000603	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CNR2—osteoporosis	0.0004	0.00124	CbGpPWpGaD
Misoprostol—Headache—Zoledronate—osteoporosis	0.000398	0.0006	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—ADCY5—osteoporosis	0.000397	0.00123	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—NFATC1—osteoporosis	0.000393	0.00122	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PSMA5—osteoporosis	0.000391	0.00121	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—PSMA2—osteoporosis	0.000391	0.00121	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DKK1—osteoporosis	0.00039	0.00121	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—P4HB—osteoporosis	0.000389	0.00121	CbGpPWpGaD
Misoprostol—Vomiting—Conjugated Estrogens—osteoporosis	0.000388	0.000586	CcSEcCtD
Misoprostol—Abdominal pain—Estradiol—osteoporosis	0.000387	0.000583	CcSEcCtD
Misoprostol—Body temperature increased—Estradiol—osteoporosis	0.000387	0.000583	CcSEcCtD
Misoprostol—Rash—Conjugated Estrogens—osteoporosis	0.000385	0.000581	CcSEcCtD
Misoprostol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000385	0.000581	CcSEcCtD
Misoprostol—Headache—Conjugated Estrogens—osteoporosis	0.000383	0.000577	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—PTH—osteoporosis	0.000378	0.00117	CbGpPWpGaD
Misoprostol—Nausea—Zoledronate—osteoporosis	0.000377	0.000569	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—WNT1—osteoporosis	0.000376	0.00117	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—RAP1A—osteoporosis	0.000372	0.00115	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CNR2—osteoporosis	0.000369	0.00114	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—ADCY5—osteoporosis	0.000366	0.00114	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—FGA—osteoporosis	0.000365	0.00113	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CALCA—osteoporosis	0.000364	0.00113	CbGpPWpGaD
Misoprostol—Nausea—Conjugated Estrogens—osteoporosis	0.000363	0.000547	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—NFATC1—osteoporosis	0.000363	0.00113	CbGpPWpGaD
Misoprostol—Hypersensitivity—Estradiol—osteoporosis	0.00036	0.000543	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—ADCY5—osteoporosis	0.00036	0.00112	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DKK1—osteoporosis	0.00036	0.00112	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—POMC—osteoporosis	0.000355	0.0011	CbGpPWpGaD
Misoprostol—Asthenia—Estradiol—osteoporosis	0.000351	0.000529	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—WNT1—osteoporosis	0.000347	0.00108	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PTHLH—osteoporosis	0.00034	0.00105	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—BMP2—osteoporosis	0.00034	0.00105	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—FGA—osteoporosis	0.000337	0.00105	CbGpPWpGaD
Misoprostol—Diarrhoea—Estradiol—osteoporosis	0.000335	0.000505	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FGB—osteoporosis	0.000332	0.00103	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—ADCY5—osteoporosis	0.000332	0.00103	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—KL—osteoporosis	0.000331	0.00103	CbGpPWpGaD
Misoprostol—Dizziness—Estradiol—osteoporosis	0.000323	0.000488	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—POMC—osteoporosis	0.000323	0.001	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PSMA2—osteoporosis	0.000321	0.000996	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—PSMA5—osteoporosis	0.000321	0.000996	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6R—osteoporosis	0.000315	0.000977	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PTHLH—osteoporosis	0.000314	0.000973	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—BMP2—osteoporosis	0.000314	0.000973	CbGpPWpGaD
Misoprostol—Vomiting—Estradiol—osteoporosis	0.000311	0.000469	CcSEcCtD
Misoprostol—Rash—Estradiol—osteoporosis	0.000308	0.000465	CcSEcCtD
Misoprostol—Dermatitis—Estradiol—osteoporosis	0.000308	0.000465	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FGB—osteoporosis	0.000307	0.000953	CbGpPWpGaD
Misoprostol—Headache—Estradiol—osteoporosis	0.000306	0.000462	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CALCA—osteoporosis	0.000299	0.000929	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PSMA2—osteoporosis	0.000296	0.00092	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—PSMA5—osteoporosis	0.000296	0.00092	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—POMC—osteoporosis	0.000292	0.000906	CbGpPWpGaD
Misoprostol—Nausea—Estradiol—osteoporosis	0.00029	0.000438	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CALCA—osteoporosis	0.000276	0.000857	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—KL—osteoporosis	0.000272	0.000843	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—POMC—osteoporosis	0.000269	0.000836	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—POMC—osteoporosis	0.000265	0.000822	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ADCY5—osteoporosis	0.000259	0.000804	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6R—osteoporosis	0.000258	0.000802	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—KL—osteoporosis	0.000251	0.000778	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—SPP1—osteoporosis	0.000251	0.000778	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—POMC—osteoporosis	0.000244	0.000759	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6R—osteoporosis	0.000239	0.00074	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IRS2—osteoporosis	0.000227	0.000704	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—LEP—osteoporosis	0.000222	0.000689	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ADCY5—osteoporosis	0.000213	0.000661	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ESR1—osteoporosis	0.000212	0.000658	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—SPP1—osteoporosis	0.000206	0.000639	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IRS1—osteoporosis	0.000198	0.000614	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ADCY5—osteoporosis	0.000196	0.00061	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—POMC—osteoporosis	0.000191	0.000592	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—SPP1—osteoporosis	0.00019	0.00059	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IRS2—osteoporosis	0.000186	0.000578	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6R—osteoporosis	0.000186	0.000577	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IGF1—osteoporosis	0.000183	0.000569	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—LEP—osteoporosis	0.000182	0.000566	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ESR1—osteoporosis	0.000174	0.00054	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IRS2—osteoporosis	0.000172	0.000533	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—LEP—osteoporosis	0.000168	0.000522	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IRS1—osteoporosis	0.000163	0.000505	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ESR1—osteoporosis	0.000161	0.000498	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—POMC—osteoporosis	0.000157	0.000486	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6R—osteoporosis	0.000153	0.000474	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IGF1—osteoporosis	0.000151	0.000467	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IRS1—osteoporosis	0.00015	0.000466	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—POMC—osteoporosis	0.000144	0.000448	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6R—osteoporosis	0.000141	0.000437	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—osteoporosis	0.00014	0.000435	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IGF1—osteoporosis	0.000139	0.000431	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—osteoporosis	0.000115	0.000357	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—MYC—osteoporosis	0.00011	0.000342	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—TGFB1—osteoporosis	0.00011	0.000341	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—osteoporosis	0.000106	0.00033	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—MYC—osteoporosis	9.05e-05	0.000281	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—TGFB1—osteoporosis	9.03e-05	0.00028	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—MYC—osteoporosis	8.35e-05	0.000259	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—TGFB1—osteoporosis	8.33e-05	0.000259	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—osteoporosis	8.28e-05	0.000257	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—osteoporosis	6.8e-05	0.000211	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—osteoporosis	6.28e-05	0.000195	CbGpPWpGaD
